Nymox Pharmaceutical Corp
NYMX
NYMX was delisted on the 6th of July, 2023.
1 hedge funds and large institutions have $2.06K invested in Nymox Pharmaceutical Corp in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 1 → 1 (0)
50% less capital invested
Capital invested by funds: $4.13K → $2.06K (-$2.08K)
Top Buyers
Top Sellers
NYMX Hedge Fund Activity: Q3 2025 in Review
1 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q3 2025, worth a combined $2.06K — down 50% from $4.13K a quarter earlier.
Fund positioning in NYMX was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 1 institutional investor held Nymox Pharmaceutical Corp (NYMX) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $2.06K of Nymox Pharmaceutical Corp stock for Q3 2025, down 50% quarter-over-quarter.
- 0 funds opened new Nymox Pharmaceutical Corp positions in Q3 2025 and 0 closed out.
Based on aggregated 13F filings for Q3 2025.